Finance

Lists
GALE:SWX
Galenica AG
CHF 83.10
-0.30%
(-0.25) 1D
Aug 26, 4:24:19 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for GALE...
Open
CHF 83.05
High
CHF 83.75
Low
CHF 82.85
Mkt. cap
4.15B
Avg. vol.
81.97K
Volume
24.68K
Dividend
3.01%
Quarterly dividend
CHF 0.63
Ex-dividend date
Apr 23, 2026
P/E ratio
26.05
52-wk high
CHF 103.00
52-wk low
CHF 80.30
EPS
CHF 3.19
Shares outstanding
50.00M
No. of employees
7K
Open
CHF 83.05
High
CHF 83.75
Low
CHF 82.85
Mkt. cap
4.15B
Avg. vol.
81.97K
Volume
24.68K
Dividend
3.01%
Quarterly dividend
CHF 0.63
Ex-dividend date
Apr 23, 2026
P/E ratio
26.05
52-wk high
CHF 103.00
52-wk low
CHF 80.30
EPS
CHF 3.19
Shares outstanding
50.00M
No. of employees
7K
Profile
Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange and are a component of the SMI MID index. Wikipedia
About Galenica AG
CEO-
Employees6.62K
Founded1927
Headquarters-
SectorHealth care provider
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (CHF)
CHF 1.83 / -
0.00%miss
Revenue / Est. (CHF)
2.14B / -
0.00%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.07B
1.07B
1.07B
1.07B
Cost of goods sold
946.00M
946.00M
929.61M
929.61M
Cost of revenue
946.00M
946.00M
929.61M
929.61M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.62M
3.62M
-
-
Operating expense
64.49M
64.49M
100.30M
100.30M
Total operating expenses
1.01B
1.01B
1.03B
1.03B
Operating income
60.49M
60.49M
41.72M
41.72M
Other non operating income
-2.72M
-2.72M
-426.00K
-426.00K
EBT including unusual items
57.93M
57.93M
40.18M
40.18M
EBT excluding unusual items
55.80M
55.80M
40.18M
40.18M
Income tax expense
10.32M
10.32M
6.54M
6.54M
Effective tax rate
17.80%
17.80%
16.29%
16.29%
Other operating expenses
30.33M
30.33M
58.63M
58.63M
Net income
46.41M
46.41M
33.18M
33.18M
Net profit margin
4.33%
4.33%
3.10%
3.10%
Earnings per share
-
-
-
-
Interest and investment income
199.00K
199.00K
268.50K
268.50K
Interest expense
-3.58M
-3.58M
-3.77M
-3.77M
Net interest expenses
-3.39M
-3.39M
-3.50M
-3.50M
Depreciation and amortization charges
30.54M
30.54M
41.67M
41.67M
EBITDA
66.62M
66.62M
66.10M
66.10M
Gain or loss from assets sale
-37.00K
-37.00K
-39.00K
-39.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps